Samira, C.P. and Andrisa, R.S. 2017. Efficacy and Safety of Imiquimod 5% as Primary Therapy in Management of Nodular Basal Cell Carcinoma of the Eyelid. Ophthalmologica Indonesiana. 42, 2 (Feb. 2017). DOI:https://doi.org/10.35749/journal.v42i2.80.